The Positioning of Lithium in Recent Guidelines on the Treatment of Bipolar Disorder

来源 :2014第五届国际神经科技大会暨2014首届国际高科技针灸和中西医结合大会 | 被引量 : 0次 | 上传用户:itsmoreaaron
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Still after more than 50 years lithium is a major treatment of bipolar disorder.Accordingly, lithium has a major position in various treatment guidelines on bipolar disorder.This presentation will in more details discuss the position of lithium in the recent updates of treatment guidelines on bipolar disorder from the World Federation of Societies for Biological Psychiatry (WFSBP).
其他文献
Chronic pain is a major heath problem worldwide, but currently available therapeutics are often ineffective or with serious side effects.Despite the rapid advances of modern neuroscience research tech
会议
The last two decades of research into chronic pain have brought a revolution in our thinking concerning the molecules that are involved in chronic pain states.Yet, this increase in understanding has n
会议
Cortical spreading depression (CSD) is a temporary disruption of local ionic homeostasis, followed by depression that propagates slowly across the cortex.This phenomenon is believed to promote changes
会议
Migraine is a complex disorder lasting many hours to days and consists of unilateral, throbbing headache combined with nausea, photo/phonophobia, aura, and worsening of headache with physical activity
会议
Treatment of neuropathic pain remains an unmet clinical challenge.Excessive activation of glutamate receptors in the spinal dorsal horn is one of the most critical mechanisms leading to abnormal neuro
会议
Pain is a very common symptom in many conditions.Around one-third of Australians are in pain; one in five is reporting that his/her pain is constant and more than one-third of the worlds population su
会议
Currently, prolonged and neuropathic pain is the most prevalent disease in the world with over 100 million people in the U.S.A.and 1.5 billion people in the world suffering every day.Moreover, there i
会议
The Treatment Guideline Subcommittee of the Taiwan Headache Society evaluated the medications currently used for acute and preventive therapy of migraine in Taiwan according to the principles of evide
会议
Between 10 to 15% of all patients presenting for the treatment of a major depressive episode will not respond to 3 or more medication trials and are considered to have treatment resistant depression (
会议
In the past two decades, we have demonstrated that inflammation could significantly contribute to the aetiology of depression and neurodegeneration.First, we demonstrated that only proinflammatory but
会议